Express Scripts Sues Maker of Injectable Naloxone


The prescription management company Express Scripts is suing the maker of the injectable naloxone drug Evzio. The price of the drug, which reverses opioid overdoses, quintupled last year. Express Scripts claims it is owed more than $14.5 million in fees and rebates related to Evzio, which is made by the drug company Kaléo. Evzio is no longer on Express Scripts’ preferred drug list, The New York Times reports. Kaléo said the price increase was meant to cover the cost of a new patient-assistance program that decreases the out-of-pocket costs for patients who cannot afford the drug. The company covers all out-of-pocket costs for patients with private insurance. For uninsured patients making less than $100,000 per year, the company offers Evzio at no cost. Critics say these programs increase the price of drugs because they leave insurance companies to pay most of the costs, particularly when a less expensive version is available....

Continue reading
  2874 Hits

Family Can Play Lifesaving Role in Overdoses by Using Naloxone


Family members can be active participants in responding to the overdose epidemic by rescuing loved ones with the opioid overdose antidote naloxone, a new study finds. Boston University researchers studied almost 41,000 people who underwent naloxone training, and found family members used the antidote in about 20 percent of 4,373 rescue attempts. Almost all the attempts were successful, HealthDay reports. “Families are willing participants in this fight against overdose deaths, and more should be done to involve them as allies,” lead researcher Sarah Bagley said.The study appears in Drug and Alcohol Review.

  1898 Hits

Free Doses of Naloxone for College Students Overdosing on Heroin and Other Opioids

Free Doses of Naloxone for College Students Overdosing on Heroin and Other Opioids

Colleges will be able to get several free doses of a drug that can reverse opioid overdoses, a sign of the widening impact of the deadly epidemic and increased efforts to combat it. The Clinton Foundation and Adapt Pharma are working together to give colleges 40,000 doses of NARCAN nasal spray, the only FDA-approved nasal spray. It is designed to be simple enough to administer that people without medical training can provide a potentially lifesaving dose. More than 33,000 people died of opioid overdoses in 2015, according to the Centers for Disease Control and Prevention (CDC), exceeding the number killed by guns for the first time. “The program has three goals: education, awareness and expansion of naloxone,” said Mike Kelly, the U.S. president of Adapt Pharma. “There’s a stigma about the disease and getting people to talk about it in an open forum, in schools, is a good place to start....

Continue reading
  2263 Hits